Zynlonta

loncastuximab tesirine · ADC Therapeutics

Drug timelines are a Plus or Pro feature.

18 regulatory and trial events tracked for Zynlonta, covering 2021-04-23 to 2026-08-06. Get the full timeline:

Most recent: EMA Authorised: Zynlonta (loncastuximab tesirine) — Swedish Orphan Biovitrum AB